StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.51−0.02 (-1.31%)

Close on Nov 13, 2026Market cap $850.64KP/E –Yield –

Universe Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -16.3%, against -34.8% the year before. The highest annual figure on record is 33.4% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-16.3%+18.5
FY2024Sep 30, 2024-34.8%−22.6
FY2023Sep 30, 2023-12.3%+5.2
FY2022Sep 30, 2022-17.5%−45.8
FY2021Sep 30, 202128.3%−5.1
FY2020Sep 30, 202033.4%+4.0
FY2019Sep 30, 201929.4%–

More Universe Pharmaceuticals figures

See a number that looks wrong?